Contracts › FA238424CB015
FA238424CB015: Non-Surgical Control of Junctional and Non-Compressible Hemorrhage Via Percutaneously Delivered Adjustable Vessel Occlusion
Awarded to Amsel Medical Corporation by Department of the Air Force.
$5.5Mobligated
$5.5Mpotential value
29 April 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | FA238424CB015 |
|---|---|
| Awardee | Amsel Medical Corporation |
| Awarding agency | Department of the Air Force |
| Awarding office | FA2384 USAF AFMC AFRL PZL AFRL RAKH |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AC12 National Defense R&D Services; Department of Defense - Military; Applied Research |
| Place of performance | MA |
| Offers received | 1 |
| Period of performance | 30 September 2024 to 29 April 2027 |
| Potential end | 29 April 2027 |
| Estimated recompete solicitation | ~Q4 2026 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record